|
31 Aug 2025 |
Colgate-Palmolive
|
Consensus Share Price Target
|
2331.80 |
2518.81 |
- |
8.02 |
hold
|
|
|
|
|
16 May 2024
|
Colgate-Palmolive
|
Axis Direct
|
2331.80
|
2500.00
|
2686.30
(-13.20%)
|
Target met |
Hold
|
|
|
With a limited upside potential from the CMP, we ascribe a HOLD rating to the stock.
|
|
15 May 2024
|
Colgate-Palmolive
|
ICICI Securities Limited
|
2331.80
|
2900.00
|
2672.55
(-12.75%)
|
Target met |
Hold
|
|
|
While Colgate’s revenue and profit growth beat peers (price/mix +8%, volumes +2%, albeit on a low base), it's still underwhelming. At ~70% gross margin and >35% adj. EBITDA margin, it is over-earning, though the basic product (white toothpaste with the highest salience in its portfolio) is a functional product.
|
|
15 May 2024
|
Colgate-Palmolive
|
Emkay
|
2331.80
|
2350.00
|
2672.55
(-12.75%)
|
Target met |
Sell
|
|
|
Our SELL call on Colgate has been a factor of limited visibility on earnings over the medium term, given that high margin gets into the base and structural growth remain elusive.
|
|
23 Jan 2024
|
Colgate-Palmolive
|
Axis Direct
|
2331.80
|
2350.00
|
2438.40
(-4.37%)
|
|
Hold
|
|
|
Recommendation With a limited upside potential from the CMP, we ascribe a HOLD rating on the stock.
|
|
22 Jan 2024
|
Colgate-Palmolive
|
Motilal Oswal
|
2331.80
|
2400.00
|
2536.20
(-8.06%)
|
Target met |
Neutral
|
|
|
|
|
13 Dec 2023
|
Colgate-Palmolive
|
IDBI Capital
|
2331.80
|
2375.00
|
2391.15
(-2.48%)
|
Target met |
Buy
|
|
|
|
|
27 Oct 2023
|
Colgate-Palmolive
|
ICICI Securities Limited
|
2331.80
|
2200.00
|
2034.40
(14.62%)
|
Target met |
Accumulate
|
|
|
2QFY24 revenue growth was below our and consensus estimates but PAT was above estimates driven by higher other income. Colgate reported domestic revenue growth of ~7% (high-single digit growth in toothpaste portfolio), which appears to be driven by balanced volume and price/mix growth.
|
|
27 Oct 2023
|
Colgate-Palmolive
|
Axis Direct
|
2331.80
|
2100.00
|
2080.50
(12.08%)
|
Target met |
Hold
|
|
|
Pricing Led the Growth: Q2FY24 results were ahead of our estimates. The company's revenue grew by 6.1% YoY (Domestic sales grew by 6.6%), while volume stood flat
|
|
26 Oct 2023
|
Colgate-Palmolive
|
Prabhudas Lilladhar
|
2331.80
|
1948.00
|
2034.40
(14.62%)
|
|
Hold
|
|
|
|
|
27 Sep 2023
|
Colgate-Palmolive
|
IDBI Capital
|
2331.80
|
2375.00
|
2050.40
(13.72%)
|
Target met |
Buy
|
|
|
|